Curate Biosciences pioneers advanced methods for autologous CAR-T cell separation, enhancing the precision of cancer therapy. By refining cell isolation techniques, Curate accelerates the development of personalized treatments, bolstering the effectiveness of Chimeric Antigen Receptor T-cell therapy in targeting and eradicating cancer cells.
